Efficacy, safety, and cost of new anticancer drugs. Price needs to be evaluated against effectiveness.

BMJ (Clinical research ed.)

Volumn 325, Issue 7375, 2002, Pages

  Messori, Andrea ^a   Trippoli, Sabrina ^a   Vaiani, Monica ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

DRUG COST; ECONOMICS; HUMAN; ITALY; NOTE; PHARMACOECONOMICS; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; DRUG COSTS; ECONOMICS, PHARMACEUTICAL; HUMANS; ITALY; TREATMENT OUTCOME;

EID: 18244425354     PISSN: None     EISSN: 14685833     Source Type: Journal    
DOI: None     Document Type: Note

References (0)